[go: up one dir, main page]

AR093707A1 - Comprimido masticable que comprende un inhibidor de la fosfodiesterasa-5 - Google Patents

Comprimido masticable que comprende un inhibidor de la fosfodiesterasa-5

Info

Publication number
AR093707A1
AR093707A1 ARP130104461A ARP130104461A AR093707A1 AR 093707 A1 AR093707 A1 AR 093707A1 AR P130104461 A ARP130104461 A AR P130104461A AR P130104461 A ARP130104461 A AR P130104461A AR 093707 A1 AR093707 A1 AR 093707A1
Authority
AR
Argentina
Prior art keywords
inhibitor
phosphodesterase
oral cavity
tablet included
masticable tablet
Prior art date
Application number
ARP130104461A
Other languages
English (en)
Inventor
Il Kim Yong
Woo Jeong Ki
Jeong Hayoung
Soo Kim Kyeong
Hyun Park Jae
Soo Woo Jong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of AR093707A1 publication Critical patent/AR093707A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Comprimido masticable que comprende un inhibidor de la fosfodiesterasa-5 (PDE-5) y un disgregante que tiene un coeficiente de hinchazón que se encuentra en el rango de entre 4 y 8 l/kg que puede tomarse sin agua, sin causar sensación de irritación en la cavidad bucal y, por lo tanto, puede mejorar el cumplimiento y la satisfacción del paciente; también exhibe una rápida disgregación en la cavidad bucal, por lo tanto, puede ser útil como un agente terapéutico en el tratamiento de la disfunción eréctil masculina humana.
ARP130104461A 2012-12-14 2013-12-03 Comprimido masticable que comprende un inhibidor de la fosfodiesterasa-5 AR093707A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020120146705A KR101953735B1 (ko) 2012-12-14 2012-12-14 포스포다이에스터라제-5 억제제를 포함하는 츄정

Publications (1)

Publication Number Publication Date
AR093707A1 true AR093707A1 (es) 2015-06-17

Family

ID=50934596

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130104461A AR093707A1 (es) 2012-12-14 2013-12-03 Comprimido masticable que comprende un inhibidor de la fosfodiesterasa-5

Country Status (4)

Country Link
KR (1) KR101953735B1 (es)
AR (1) AR093707A1 (es)
TW (1) TW201427721A (es)
WO (1) WO2014092358A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112826802B (zh) * 2021-01-22 2021-09-28 上海普康药业有限公司 一种枸橼酸西地那非咀嚼片及其制备方法
CN115337276B (zh) * 2021-05-14 2024-02-09 南京科默生物医药有限公司 一种枸橼酸西地那非口腔崩解片剂的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9311920D0 (en) 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
GB9401090D0 (en) 1994-01-21 1994-03-16 Glaxo Lab Sa Chemical compounds
IL135462A0 (en) 1997-11-12 2001-05-20 Bayer Ag 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
KR100353014B1 (ko) 1998-11-11 2002-09-18 동아제약 주식회사 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물
KR100435514B1 (ko) * 2002-03-22 2004-06-10 한미약품 주식회사 실데나필 젖산염의 속효제형
GB0219516D0 (en) * 2002-08-21 2002-10-02 Phoqus Ltd Fast dissolving and taste masked oral dosage form comprising sildenafil
JP2008127320A (ja) 2006-11-20 2008-06-05 Zensei Yakuhin Kogyo Kk 口腔内速崩壊性固形製剤
WO2009074995A1 (en) 2007-12-10 2009-06-18 Ajanta Pharma Limited Taste masked chewable compositions of sildenafil citrate
WO2011030351A2 (en) 2009-09-03 2011-03-17 Rubicon Research Private Limited Taste - masked pharmaceutical compositions
EP2338474A1 (de) * 2009-12-23 2011-06-29 Ratiopharm GmbH Oral dispersible Tablette enthaltend kompaktierte Sildenafil-Base
JP5292361B2 (ja) * 2010-06-23 2013-09-18 日立建機株式会社 作業機械
WO2012120522A1 (en) * 2011-03-04 2012-09-13 Genepharm India Private Limited A taste masked chewable tablet of sildenafil

Also Published As

Publication number Publication date
WO2014092358A1 (en) 2014-06-19
TW201427721A (zh) 2014-07-16
KR20140077658A (ko) 2014-06-24
KR101953735B1 (ko) 2019-03-04

Similar Documents

Publication Publication Date Title
MX2021002321A (es) Nuevos metodos.
MX2021002322A (es) Nuevos metodos.
PH12016501139B1 (en) Bicyclic heterocycle compounds and their uses in therapy
MX2011007589A (es) Tratamiento de un cancer usando una combinacion de bendamustine y un anticuerpo anti-cd20.
MX365427B (es) Composiciones transdermicas de ibuprofeno y metodos de uso de las mismas.
CL2013001136A1 (es) Un agente inhibitorio de la fosfodiesterasa 7 (pde7) para ser usado en el tratamiento o la reduccion de la posibilidad de una adiccion; y composicion farmaceutica, forma de dosificacion unitaria y kit farmaceutico que incluyen al inhibidor de fosfodiesterasa 7 (pde7) y un agente terapeutico adicional.
MX2011011109A (es) Formulaciones orales de bendamustina.
ECSP17019893A (es) Tratamientos médicos a base de anamorelina
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
CO6480985A2 (es) Formulaciones para el tratamiento del dolor tisular profundo
CL2015001869A1 (es) Composición inyectable acuosa de diclofenaco en una solucion de eter monoetilico de dietilenglicol y agua; metodo de preparacion; y uso en el tratamiento o prevencion del dolor y/o condiciones inflamatorias como dolor de cabeza, dolor de garganta, entre otras.
CL2014002706A1 (es) Formulaciones vesiculares que comprenden un fosfolipido y un agente tensoactivo y el uso en el tratamiento del dolor o movilidad reducida de una articulación.
MX2016014913A (es) Dispositivo y formulacion para el tratamiento topico de dolor que afecta a la zona vulvar del organo genital humano femenino.
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2016014307A (es) Administración asistida de agentes de tratamiento de plantas.
ECSP12011629A (es) Fulvestrant en una dosis de 500 mg para el tratamiento del cáncer de mama avanzado
AR093707A1 (es) Comprimido masticable que comprende un inhibidor de la fosfodiesterasa-5
MY182801A (en) Compound for activating ampk and uses thereof
MX2020006075A (es) Composiciones farmaceuticas de bendamustina.
IN2015DN00966A (es)
CL2016002655A1 (es) Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol
MX2025002392A (es) Formulaciones de dantroleno y metodos de uso de dichas formulaciones
GEP20196947B (en) Bremelanotide therapy for female sexual dysfunction
Jian-yu Male Sexual Function and Sexual Dysfunction
RU2009119225A (ru) Способ лечения и профилактики кокцидиозов норок

Legal Events

Date Code Title Description
FB Suspension of granting procedure